Australia Prepares For Future Challenges In Regulatory Science
Regulator’s five-year plan to build up expertise
With ever more new technologies on the horizon, the Australian regulatory authorities have come up with a range of actions to help them increase their ability to assess the new and innovative products that will be coming their way.
You may also be interested in...
The bedding-in period is ending for Europe’s one-year-old system for preventing the circulation of fake medicines, and the scheme is gearing up for a more fully operational stage.
EU and US regulators have opposing views when it comes to Merck's applications for a new indication and new dosing schedule for the company's successful PD-1 inhibitor Keytruda.
Regulators have pulled out all the stops in their efforts to get the Ebola vaccine to the marketing authorization stage in Africa.